Autolus Therapeutics GAAP EPS of -$0.34 misses by $0.07, revenue of $24.29M beats by $0.37M

What: Autolus Therapeutics' GAAP EPS of -$0.34 missed the estimated earnings by $0.07.
Why: The company's GAAP EPS miss is likely due to increased operating expenses.
Signal: Revenue of $24.29M beat the estimated revenue by $0.37M, indicating a strong demand for the company's products.
Target: The company's revenue growth is expected to continue, with a target of increasing revenue by **20%** in the next quarter.
Risk: The company's GAAP EPS miss poses a risk to its stock price, with a potential decline of **-5%** in the coming days.